ISAL 2019 | European LeukemiaNet 2017 AML recommendations: impact on risk stratification and survival

Klaus Metzeler

Klaus Metzeler, MD, of LMU Hospital Munich, Munich, Germany, discusses what changes came about from the 2017 European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults. This interview was recorded at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video